A Ketamine-Based Nasal Spray for Depression Could Soon be Approved by the FDA

Gizmodo ---------- One of the largest hurdles to ketamine becoming a mainstream depression treatment may have just been cleared. On Tuesday, an independent expert panel convened by the Food and Drug Administration discussed whether a nasal spray version of the drug developed by Johnson & Johnson should be approved by the FDA. In a majority vote, they agreed that the drug’s benefits outweighed its risks in treating cases of depression that haven’t responded to other treatments, though not without some conditions. The vote all but signals the drug’s eventual approval, since the FDA rarely strays from these decisions. To learn more click on the picture below to read the article.